A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients

NCT04255602 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

2120

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome
Coronary Stent Implantation

Interventions

DRUG: Ticagrelor 60mg
DRUG: Ticagrelor 90mg

Sponsor

Shanghai Tong Ren Hospital

Collaborators

[object Object]
[object Object]